Remicade 100 mg Powder for concentrate for solution for infusion
- Licence status
- Active substances
- Infliximab
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/99/116/001-5
- Licence holder
- Janssen-Cilag International NV
Product documents
Licence information
- ATC code
- L04AB Tumor necrosis factor alpha (TNF-) inhibitors, L04AB02 infliximab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued